Previous studies have found that PD‐1 expression is significantly increased in peripheral blood CD3+ T lymphocytes of patients with Hodgkin's lymphoma, chronic lymphocytic leukemia, and multiple myeloma. This evidence concerns the gene PDCD1 and plasma cell myeloma.